How V5 Ultimate runs a veterinary pharma site, end to end.

Veterinary drugs live under 21 CFR 514 (NADA / ANADA) for the product, 21 CFR 211 for cGMP, 21 CFR 226 / 225 for medicated feeds, and the VICH harmonised guidelines (Q1A through GL47) for technical content. In the EU, Regulation 2019/6 plus EU GMP Part 1 govern. The unique vet-pharma overlay is the withdrawal time / withholding period — the time after dosing before the food-producing animal (or its milk / eggs) may enter the food supply.

The hazards that drive enforcement are unambiguous: off-label active concentration in a food-animal product, missing or wrong withdrawal-time statement, contaminated lot reaching a slaughter line, late or missing 514.80 adverse drug experience reports.

V5 Ultimate treats every batch, every QC release, every label print, every distribution event and every adverse-event intake as part of the same immutable ledger. Withdrawal-time data is a property of the lot, not a binder.

Every node carries forward supplier lot, NADA/ANADA reference, work order, operator, equipment, withdrawal-time data and target-species context from the node before it. Nothing is re-keyed.

Each API supplier is qualified per the approved NADA / ANADA source. Substituting an API source is a CMC change controlled through the formal regulatory pathway. V5 holds the approved-source list per product per submission and blocks goods-in from any other source. ICH Q7 expectations on supplier audit and on-going qualification are operationalised.

Excipient suppliers are qualified per compendial monograph (USP / Ph. Eur. / JP); novel excipients require additional CMC submission. Re-qualification is calendar-driven and portal-led.

The receiver scans the BOL, weighs against PO, captures the supplier lot, retest date / expiry, and CoA. V5 mints a goods-receipt lot ID. Until QC releases against the registered specification, the lot is Quarantine and physically pickable only into a Quarantine bin — the standard for vet-pharma APIs and finished excipients.

Identity verification — visual, IR / FTIR for API identity confirmation, water content for hydroscopic actives, particle size where the formulation depends on it — runs on the same kiosk. Results link to the receipt lot, instrument, analyst e-signature and supplier CoA.

V5 maintains bin attributes: controlled-substance class (DEA where overlapped), temperature band, photosensitivity, target-species class. The pick list shown to the picker only includes bins compatible with the work order. FEFO is enforced; overrides require reason + dual e-sig.

Each MMR holds: NADA / ANADA reference, target species and route, BOM with approved source per ingredient, routing with step-by-step instructions, in-process control plan, finished-product specification, container-closure spec, registered label artwork with withdrawal-time statement, and stability / expiry rules.

Effectivity is two-signature: a formulator signs the change, a QA lead signs that the change is within the registered MMR (or that a CMC supplement has been filed). New work orders pick up the new revision; in-flight work orders keep the snapshot they were released against.

If the MMR is revised mid-shift, the work order keeps the snapshot it was released against. The auditor sees exactly the formulation this batch was built to, with the sha256 of the snapshot recorded against release.

Dispense is verified against scale stream — APIs are dual-witness where SOP requires. The compound / fill step shows the routing, the live in-process controls, and the target-species labelling that will be applied. Mis-pick at fill (wrong species label, wrong container) hard-stops the line.

Assay (HPLC / titrimetric), related substances, content uniformity, dissolution where applicable, microbial limits, endotoxin for parenterals, sterility for sterile products, container-closure integrity — all scheduled by the work order. OOS auto-opens a deviation, holds the lot, and notifies QA. Retain samples are scheduled per 21 CFR 211.170.

A single register categorises by event type. Adverse Drug Experiences under 21 CFR 514.80 are first-class objects: an ADE received from a veterinarian, owner or producer is logged with date, target species, severity, the product, the lot. The 15-day (serious unexpected) and periodic reporting clocks start automatically.

Each SKU carries: target species and route, indication, withdrawal time per species, dosage, lot, expiry, NDC / NADA, manufacturer / distributor statement. V5 carries those fields from the MMR through to the printed label — no manual artwork edits at packaging.

Distribution gates by jurisdiction: if the SKU isn't licensed in the destination country / state, the shipment cannot release.

Review-by-exception is only safe if the record is complete and immutable. V5's batch record is built from the ledger as the line runs. The QA reviewer's queue surfaces only items the system can't auto-clear. Release requires two qualified e-signatures, both identity-verified, both bound to the snapshot. In the EU, QP certification is the equivalent gate and is captured the same way.

Every container is shipped against a BOL that carries the lot code. When a recall trigger fires — ADE cluster, OOS retest, supplier withdrawal — V5 walks the ledger in both directions in seconds: every container made from this API lot, every distributor, every veterinary clinic.

Quality manual, process performance, product quality monitoring, CAPA, change management, management review — all structured workspaces, not Word documents.

Draft → Review → Approved → Effective → Periodic Review → Superseded / Retired. Two qualified signatures effect every release. Operators see only the effective revision; superseded revisions are retained per 21 CFR 211.180 retention rules.

V5 maintains a training matrix per role × line × hazard. CGMP training (21 CFR 211.25) is bounded; an expired course locks the operator out of the relevant kiosk action.

Every batch's quality signals, every CAPA, every ADE, every supplier scorecard, every internal-audit finding, every customer complaint — all stream into the management-review workspace as they happen.

V5's audit module schedules internal audits and external audits (FDA CVM, EU CA, FAMI-QS for premix). When the inspector arrives, the request list is a query.

HACCP for the manufacturing chain, FMEA for new equipment, risk register at the product level, fishbone for deviations — all template-driven and bound to the affected CAPAs and changes.

V5 holds sanitation procedures per zone × equipment × prior-product matrix, with frequency, agent, concentration, contact time and verification (visual + TOC / swab on a defined cadence). Sanitation events are kiosk-led; results bind to the equipment record.

Dispense scales, mixer torque / RPM, fillers, HPLC, GC, particle counters, dissolution baths — each is a tracked asset with calibration interval, certificate, tolerance, and an out-of-tolerance impact assessment that triggers a back-look.

Sample sites, frequency, action and alert limits, and corrective actions on a positive are all scheduled and tracked.

Intake captures lot, target species, observed effect, severity. V5 binds the complaint to the batch, surfaces adjacent batches, and triggers the ADE workflow where the report meets the threshold.

ADE intake → triage → 15-day serious unexpected vs periodic schedule → submission packet (Form 1932) assembly. The same record drives the EU pharmacovigilance commitments under Reg. 2019/6.

Every signed event carries the actor's verified identity, signature meaning, time, and a sha256 of the record. The signature row is append-only.

CoAs per lot, withdrawal-time lookups, stability commitments, recall status — all on the portal. Audit-trail of who downloaded what is automatic.

A typical site onboards in 6–10 weeks: master data import, MMR migration, kiosk training, parallel-run validation, cutover. The validation pack (URS → IQ → OQ → PQ) is built in.

Abbreviated mapping. Each link opens the full readiness guide.